SARS-CoV-2 evolution and vaccines: cause for concern?

Lancet Respir Med. 2021 Apr;9(4):333-335. doi: 10.1016/S2213-2600(21)00075-8. Epub 2021 Jan 29.

Authors

Thomas C Williams¹, Wendy A Burgers²

Affiliations

¹ Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK. Electronic address: Thomas.Christie.Williams@ed.ac.uk.
² Division of Medical Virology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral / immunology
COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 / virology
COVID-19 Vaccines / administration & dosage*
COVID-19 Vaccines / genetics
COVID-19 Vaccines / immunology
Humans
Immunogenicity, Vaccine
Mutation Rate*
Pandemics / prevention & control
RNA, Viral / genetics
SARS-CoV-2 / genetics*
SARS-CoV-2 / immunology
Sequence Analysis, RNA
Spike Glycoprotein, Coronavirus / genetics
Spike Glycoprotein, Coronavirus / immunology
Treatment Outcome
Vaccines, Synthetic / administration & dosage
Vaccines, Synthetic / genetics
Vaccines, Synthetic / immunology

Substances

Antibodies, Viral
COVID-19 Vaccines
RNA, Viral
Spike Glycoprotein, Coronavirus
Vaccines, Synthetic
spike protein, SARS-CoV-2

Associated data

ClinicalTrials.gov/NCT04505722

Grants and funding